HCP1904-3

DRUG2 trials

Sponsors

Hanmi Pharmaceutical Company Limited

Conditions

HealthyHypertension

Phase 1

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1904 in Healthy Male Volunteers.

CompletedNCT05407220

Hanmi Pharmaceutical Company LimitedHealthy

Start: 2022-06-29End: 2022-07-25Updated: 2024-10-08

Phase 3

Clinical Efficacy and Safety Evaluation of HCP1904-3 in Essential Hypertension Patients

CompletedNCT05199129

Hanmi Pharmaceutical Company LimitedHypertension

Start: 2021-11-17End: 2022-09-14Updated: 2023-09-22